Metabolic tumor volume on

• Tác giả: Kosuke Hashimoto, Hisao Imai, Hiroshi Kagamu, Kyoichi Kaira, Ichiei Kuji, Yu Miura, Atsuto Mouri, Ayako Shiono, Ou Yamaguchi
• Ngôn ngữ: eng
• Ký hiệu phân loại: 899.444 Tahitian
• Thông tin xuất bản: China : Translational lung cancer research , 2025
• Bộ sưu tập: NCBI
• ID: 749119

Tóm tắt

BACKGROUND: Nivolumab plus ipilimumab (Nivo-Ipi) is a standard treatments for metastatic or recurrent non-small cell lung cancer (NSCLC). Unlike programmed death-1 (PD-1) inhibitor monotherapy, the possible predictors of Nivo-Ipi treatment effectiveness remain unclear. Therefore, this retrospective study evaluated the prognostic relevance of 2-deoxy-2-[fluorine-18]-fluoro-d-glucose positron emission tomography ( METHODS: Among 130 eligible patients with metastatic or recurrent NSCLC who received Nivo-Ipi as initial treatment and underwent RESULTS: High MTV and TLG on CONCLUSIONS: MTV determined based on